Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors (Q35153959)

6 August 2017

1 reference

title

Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors (English)

1 reference

6 August 2017

Lebovitz HE

1

1 reference

6 August 2017

1 January 1992

1 reference

6 August 2017

1 reference

6 August 2017

44 Suppl 3

1 reference

6 August 2017

21-28

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199200443-00004

6 August 2017

0 references

cites work

[The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984]

1 reference

12 December 2020

Role of metformin in treatment of diabetes mellitus

1 reference

12 December 2020

Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients.

1 reference

12 December 2020

Influence of an ??-amylase inhibitor (BAY d 7791) on blood glucose, serum insulin and nefa in starch loading tests in rats, dogs and man

1 reference

12 December 2020

Enteroglucagon release in disaccharide malabsorption induced by intestinal alpha-glucosidase inhibition

1 reference

12 December 2020

Nibbling versus gorging: metabolic advantages of increased meal frequency

1 reference

12 December 2020

Metabolic effects of reducing rate of glucose ingestion by single bolus versus continuous sipping

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

Metabolic and nutritional effects of long-term use of guar gum in the treatment of noninsulin-dependent diabetes of poor metabolic control.

1 reference

12 December 2020

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

12 December 2020

Reduction of postprandial blood glucose by the alpha-glucosidase inhibitor Miglitol (BAY m 1099) in type II diabetes

1 reference

12 December 2020

Metformin-induced changes in serum lipids, lipoproteins, and apoproteins in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents

1 reference

12 December 2020

U.K. prospective diabetes study. II. Reduction in HbA1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study

1 reference

12 December 2020

Sulphonylureas and hypoglycaemia

1 reference

12 December 2020

Comparison of guar gum, wheat bran and placebo on carbohydrate and lipid metabolism in type II diabetics

1 reference

12 December 2020

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

12 December 2020

The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?

1 reference

12 December 2020

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

1 reference

12 December 2020

Mechanism of metformin action in non-insulin-dependent diabetes

1 reference

12 December 2020

Placebo-controlled trial of the effects of guar gum and metformin on fasting blood glucose and serum lipids in obese, type 2 diabetic patients.

1 reference

12 December 2020

Comparison of tolbutamide and metformin in elderly diabetic patients

1 reference

12 December 2020

Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.

1 reference

12 December 2020

The status of metformin in Canada

1 reference

12 December 2020

Low dose metformin in the treatment of type II non-insulin-dependent diabetes: clinical and metabolic evaluations

1 reference

12 December 2020

Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas.

1 reference

12 December 2020

Fibre in the management of diabetes. 2. Benefits of fibre itself are uncertain

1 reference

12 December 2020

Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes

1 reference

12 December 2020

Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Effects of low dose guar in non-insulin dependent diabetic patients

1 reference

12 December 2020

The acute effects of glucosidase inhibition on post-meal glucose increments in insulin-dependent diabetics

1 reference

12 December 2020

Effect of guar gum on mineral balances in NIDDM adults

1 reference

12 December 2020

Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses

1 reference

12 December 2020

Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients.

1 reference

12 December 2020

Guar gum. A review of its pharmacological properties, and use as a dietary adjunct in hypercholesterolaemia

1 reference

12 December 2020

Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone

1 reference

12 December 2020

Effects of a gel forming dietary fiber, guar gum, on the absorption of glibenclamide and metabolic control and serum lipids in patients with non-insulin-dependent (type 2) diabetes.

1 reference

12 December 2020

Cellular mechanism of action of metformin

1 reference

12 December 2020

10.2165/00003495-199200443-00004

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference

PubMed ID

1280574